Clinical trial
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
NCT00019110 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019110 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer |
| Official title | VACCINE THERAPY AND DETECTION OF IMMUNOLOGIC RESPONSES WITH HUMAN PAPILLOMAVIRUS 16 E6 AND E7 PEPTIDES IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED CERVICAL CANCER |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anal Cancer, Cervical Cancer, Esophageal Cancer, Head and Neck Cancer, Penile Cancer, Vulvar Cancer |
| Intervention type | Biological |
| Interventions | human papillomavirus 16 E7 peptide, synthetic human papillomavirus 16 E6 peptide |
| Start date | Nov 1, 1995 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: